Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs - PubMed (original) (raw)

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

I Creese et al. Science. 1976.

Abstract

Tritiated haloperidol and tritiated dopamine label postsynaptic dopamine receptors in mammalian brain. Clinical potencies of butyrophenones, phenothiazines, and related drugs correlate closely with their ability to inhibit tritiated haloperidol binding. These binding methods provide a simple in vitro means for evaluating new drugs as potential antischizophrenic agents.

PubMed Disclaimer

Similar articles

• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
  Creese I, Burt DR, Snyder SH. Creese I, et al. J Neuropsychiatry Clin Neurosci. 1996 Spring;8(2):223-6. doi: 10.1176/jnp.8.2.223. J Neuropsychiatry Clin Neurosci. 1996. PMID: 9081563
• Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
  Enna SJ, Bennett JP Jr, Burt DR, Creese I, Snyder SH. Enna SJ, et al. Nature. 1976 Sep 23;263(5575):338-41. doi: 10.1038/263338a0. Nature. 1976. PMID: 8733 No abstract available.
• Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding.
  Leysen JE, Gommeren W, Laduron PM. Leysen JE, et al. Biochem Pharmacol. 1978 Feb 1;27(3):307-16. doi: 10.1016/0006-2952(78)90233-2. Biochem Pharmacol. 1978. PMID: 23126 No abstract available.
• Agents acting on central dopamine receptors.
  Kumar N, Jain PC. Kumar N, et al. Prog Drug Res. 1977;21:409-65. doi: 10.1007/978-3-0348-7098-6_5. Prog Drug Res. 1977. PMID: 22892 Review. No abstract available.
• Essential structural features of novel antischizophrenic drugs: a review.
  Nematollahi A, Aminimoghadamfarouj N, Church WB. Nematollahi A, et al. Med Chem. 2014;10(6):541-9. doi: 10.2174/1573406410666131229150746. Med Chem. 2014. PMID: 24372388 Review.

Cited by

• Inhibition of striatal indirect pathway during second postnatal week leads to long-lasting deficits in motivated behavior.
  Olivetti PR, Torres-Herraez A, Gallo ME, Raudales R, Sumerau M, Moyles S, Balsam PD, Kellendonk C. Olivetti PR, et al. Neuropsychopharmacology. 2024 Sep 26. doi: 10.1038/s41386-024-01997-x. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 39327472
• Schizophrenia: a Narrative Review of Etiological and Diagnostic Issues.
  Oskolkova S. Oskolkova S. Consort Psychiatr. 2022 Sep 30;3(3):19-34. doi: 10.17816/CP132. eCollection 2022. Consort Psychiatr. 2022. PMID: 39044913 Free PMC article. Review.
• Adolescent oral oxycodone self-administration disrupts neurobehavioral and neurocognitive development.
  McLaurin KA, Ott RK, Mactutus CF, Booze RM. McLaurin KA, et al. Neuropharmacology. 2024 Nov 1;258:110064. doi: 10.1016/j.neuropharm.2024.110064. Epub 2024 Jul 7. Neuropharmacology. 2024. PMID: 38981578
• The Gene Expression Landscape of Disease Genes.
  García-González J, Garcia-Gonzalez S, Liou L, O'Reilly PF. García-González J, et al. medRxiv [Preprint]. 2024 Jun 21:2024.06.20.24309121. doi: 10.1101/2024.06.20.24309121. medRxiv. 2024. PMID: 38947033 Free PMC article. Preprint.
• LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons.
  Chen C, Masotti M, Shepard N, Promes V, Tombesi G, Arango D, Manzoni C, Greggio E, Hilfiker S, Kozorovitskiy Y, Parisiadou L. Chen C, et al. bioRxiv [Preprint]. 2024 Jun 8:2024.06.06.597594. doi: 10.1101/2024.06.06.597594. bioRxiv. 2024. PMID: 38895420 Free PMC article. Preprint.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database